Patents Assigned to HOBOOMLIFE BIO-TECHNOLOGY CO., LTD.
  • Patent number: 9950000
    Abstract: Disclosed is use of nicotinamide adenine dinucleotide (NADH) or a salt thereof in the preparation of drugs or health-care products for treating phenylketonuria (PKU), wherein a single dose of the NADH or a salt thereof is 1-100 mg.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: April 24, 2018
    Assignee: HOBOOMLIFE BIO-TECHNOLOGY CO., LTD.
    Inventors: Rongzhao Fu, Qi Zhang, Yuemei Liu